Biocare Medical is an innovator in developing and supplying world class automated immunohistochemistry instrumentation, and the full range of reagents for IHC lab testing. Biocare is the market leader in simultaneous Multiplex IHC tests which provide increased confidence at critical diagnostic decision points, impacting patient therapy while accelerating turnaround time. Biocare’s advanced micro-polymer™ detection enables unsurpassed specificity and sensitivity. PROMARK™ and “mouse on mouse” IHC detection kits are optimized for rat and mouse tissues and feature proprietary blocking and retrieval reagents, resulting in virtually background free IHC staining. The company’s customers include clinical histology laboratories, pharmaceutical companies, CROs, and biotechnology companies as well as academic, government, military, and other non-profit laboratories. Biocare Medical offers an expanding portfolio of integrated products to address the rapidly growing cancer and infectious disease diagnostic and research markets with novel tissue immunohistochemistry and in situ hybridization methods. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network.

Patents 44show all

  • 31
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 13
    C07K - Peptides
  • 6
    B01F - Mixing, e.g. dissolving, emulsifying, dispersing
  • 1
    B01L - Chemical or physical laboratory apparatus for general use
  • 1
    G02B - Optical elements, systems, or apparatus

Contact Information

60 Berry Dr
Pacheco, CA 94553


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2017-08-31$85,000,000Series UnknownExcellere Partners